(Alliance News) - Biotech-focused investor Arix Bioscience PLC on Wednesday turned to an interim loss on a portfolio revaluation.Arix took a GBP39.1 million loss from the change in fair of Read More
LONDON (Alliance News) - Arix Bioscience PLC on Thursday reported a significant increase in its annual net asset value, resulting from an upwards revaluation of its portfolio.For 2018, the Read More
LONDON (Alliance News) - Healthcare company Arix Bioscience PLC said on Tuesday it has reappointed Chief Investment Officer Joe Anderson as chief executive officer with immediate first stepped in Read More
LONDON (Alliance News) - Arix Bioscience PLC on Friday said its portfolio company Harpoon Therapeutics Inc has announced the pricing of its initial public offering on the Nasdaq stock market in at Read More
LONDON (Alliance News) - Life science company Arix Bioscience PLC said on Wednesday it has appointed Arthur Pappas as non-executive director.At the same time, Non-Executive Director David a Read More
LONDON (Alliance News) - Arix Bioscience PLC on Tuesday said Chief Executive Joe Anderson has stepped down from the board with immediate effect but will not leave the chairman of Arix, Jonathan of Read More
LONDON (Alliance News) - Healthcare and life science company Arix Bioscience PLC on Friday said Christopher Chipperton had sold 3.0 million shares at a price of 155 pence per this transaction, now Read More
LONDON (Alliance News) - Arix Bioscience PLC said Monday that the value of its portfolio increased by 71% in the first half of the year, mainly driven by Autolus Therapeutics PLC initial public in Read More
(Correcting Syncona and Woodford's shareholding value in Autolus Therapeutics following the ADS offering)LONDON (Alliance News) - Healthcare investor Syncona Ltd said Friday that its an Read More
LONDON (Alliance News) - Healthcare and life sciences company Arix Bioscience PLC on Thursday said that its Non-Executive Director James Hutton will step down immediately."It has been Read More
LONDON (Alliance News) - Healthcare company Arix Bioscience PLC said Thursday that its group business Iterum Therapeutics, which develops anti-infectives to combat multi-drug resistant diseases, Read More
LONDON (Alliance News) - Arix Bioscience PLC on Tuesday noted the planned Nasdaq listing by its largest investee Autolus Therapeutics Ltd.Autolus - in which Arix held an 8.6% stake as of of Read More
